Doxorubicin and cyclophosphamide adjuvant chemotherapy is no more effective than cyclophosphamide, methotrexate, and 5-fluorouracil for premenopausal axillary lymph node positive breast cancer: There is no clear evidence that HER-2 status affects the relative effects of doxorubicin and cyclophosphamide vs cyclophosphamide, methotrexate and 5-fluorouracil in women with operable breast cancer

✍ Scribed by Dino Amadori

• Book ID: 114483762
• Publisher: Elsevier Science
• Year: 2001
• Tongue: English
• Weight: 346 KB
• Volume: 2
• Category: Article
• ISSN: 1363-4054
• DOI: 10.1054/ebon.2001.0102